Immunological aspects of cancer chemotherapy
By L. Zitvogel, L. Apetoh, François Ghiringhelli, Guido Kroemer. Nature reviews. Immunology, 2008
949 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/482fd04d34849460ed29e941b27b7ed7ed678aa8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- M. Pittet
- C. June
- Matthias Nahrendorf
- Bostjan Seruga
- Hans Clevers
- Ralph Weissleder
- F. Swirski
- I. Tannock
In Oncology
Citations in the corpus
- Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021, background): “Although chemotherapy and radiation therapy possess cytostasis and cytotoxicity abilities [7], these approaches are often linked with acute side effects and a high risk of recurrences.”
- Origins of tumor-associated macrophages and neutrophils (2012, background): “With accumulating evidence indicating the immune system as critical for tumorigenesis, an emerging concept for fighting established cancer involves identifying drug combinations that not only kill cancer cells but influence the immune system in such a way as to be favorable to the host (43).”
- Cytokines and their relationship to the symptoms and outcome of cancer (2008, background): “Chemotherapy-induced death of cancer cells can cause the release of immunogenic antigens, which result in a cell-mediated immune response to the tumour, as recently reviewe”
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (2011, result): “The present results do not exclude a role for chemotherapy in potentiating the effects of CARs, and a number of studies suggest plausible mechanisms for coordinate effects of chemotherapy and CAR T cells (31, 32) in addition to the lymphodepleting aspects of chemotherapy, which promotes homeostatic ”
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients (2019, background): “Plausible explanations include the absence of stroma and an immune system in PDO cultures, which can dictate treatment outcome in various ways (8).”